Skip to main content
Log in

Levofloxacin/pembrolizumab

Various toxicities: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kethireddy N, et al. Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab. Journal of Oncology Pharmacy Practice 27: 207-211, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1177/1078155220921543

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Levofloxacin/pembrolizumab. Reactions Weekly 1843, 224 (2021). https://doi.org/10.1007/s40278-021-91326-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-91326-1

Navigation